Herbal Extract Shows Promise for Polycystic Ovary Syndrome in Rats

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder affecting millions of women globally, characterized by hormonal imbalances, ovulatory dysfunction, and metabolic disturbances. Current treatments often manage symptoms but lack a comprehensive approach to address the underlying pathology. This study investigates the potential of Costus speciosus, a plant traditionally used in herbal medicine, to ameliorate PCOS phenotypes in an animal model, specifically addressing the knowledge gap regarding its efficacy and mechanisms in mitigating letrozole-induced PCOS.

Treatment with Costus speciosus extract significantly improved several PCOS-related parameters compared to the letrozole-only group. Ovarian morphology showed a marked improvement, with the 200 mg/kg dose leading to a 65% reduction in the number of ovarian cysts and a 40% increase in healthy follicular development. Hormonal imbalances were also significantly corrected; serum testosterone levels decreased by 43% (p<0.01) and luteinizing hormone (LH) levels by 38% (p<0.05) in the high-dose group. The most significant finding was the 2.5-fold increase in insulin sensitivity and a 30% reduction in fasting glucose levels (p<0.001) in rats treated with 200 mg/kg Costus speciosus, indicating a strong metabolic benefit. Furthermore, inflammatory markers such as TNF-α were reduced by 28%, suggesting an anti-inflammatory effect. These findings collectively demonstrate a comprehensive ameliorative effect of the extract on both reproductive and metabolic aspects of PCOS.